Advancing Nuclear Medicine Through Innovation
Seiten
2007
National Academies Press (Verlag)
978-0-309-11067-9 (ISBN)
National Academies Press (Verlag)
978-0-309-11067-9 (ISBN)
Highlights the opportunities in nuclear medicine, which include assessing the efficacy of new drugs in development, individualizing treatment to the patient, and understanding the biology of human diseases. This book is of interest to health care and pharmaceutical professionals.
Nearly 20 million nuclear medicine procedures are carried out each year in the United States alone to diagnose and treat cancers, cardiovascular disease, and certain neurological disorders. Many of the advancements in nuclear medicine have been the result of research investments made during the past 50 years where these procedures are now a routine part of clinical care. Although nuclear medicine plays an important role in biomedical research and disease management, its promise is only beginning to be realized. Advancing Nuclear Medicine Through Innovation highlights the exciting emerging opportunities in nuclear medicine, which include assessing the efficacy of new drugs in development, individualizing treatment to the patient, and understanding the biology of human diseases. Health care and pharmaceutical professionals will be most interested in this book's examination of the challenges the field faces and its recommendations for ways to reduce these impediments.
Nearly 20 million nuclear medicine procedures are carried out each year in the United States alone to diagnose and treat cancers, cardiovascular disease, and certain neurological disorders. Many of the advancements in nuclear medicine have been the result of research investments made during the past 50 years where these procedures are now a routine part of clinical care. Although nuclear medicine plays an important role in biomedical research and disease management, its promise is only beginning to be realized. Advancing Nuclear Medicine Through Innovation highlights the exciting emerging opportunities in nuclear medicine, which include assessing the efficacy of new drugs in development, individualizing treatment to the patient, and understanding the biology of human diseases. Health care and pharmaceutical professionals will be most interested in this book's examination of the challenges the field faces and its recommendations for ways to reduce these impediments.
Committee on State of the Science of Nuclear Medicine, National Research Council
1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Nuclear Medicine; 5 3 Nuclear Medicine Imaging in Diagnosis and Treatment; 6 4 Targeted Radionuclide Therapy; 7 5 Availability of Radionuclides for Nuclear Medicine Research; 8 6 Radiotracer and Radiopharmaceutical Chemistry; 9 7 Instrumentation and Computational Sciences; 10 8 Education and Training of Nuclear Medicine Personnel; 11 References; 12 Appendix A Information-Gathering Sessions; 13 Appendix B Glossary and Acronyms; 14 Appendix C Commercially Available Radiopharmaceuticals; 15 Appendix D Biographical Sketches Of Committee Members
| Erscheint lt. Verlag | 11.10.2007 |
|---|---|
| Zusatzinfo | Illustrations (some col.) |
| Verlagsort | Washington |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Themenwelt | Medizin / Pharmazie |
| Naturwissenschaften | |
| ISBN-10 | 0-309-11067-X / 030911067X |
| ISBN-13 | 978-0-309-11067-9 / 9780309110679 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Hardcover (2024)
Referenz-Verlag
CHF 79,95
